Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Next Meeting:
Friday, June 7, 2019
10 a.m.
A public meeting will be held via telephone conference. Access to the conference call can be made at http://go.ncsu.edu/industrialhemp or by calling 1-929-205-6099 (U.S. toll) or 1-669-900-6833 (U.S. toll). The meeting ID is 474-877-760. Participants will be prompted to enter their name and email address to enter the meeting via the website, or prompted for a unique participant ID for the call. They should press # to access the call.
Purpose of this meeting: Approve research pilot program applications.
If you have questions about the meeting, please contact Beth Farrell at 919-707-3014.
RUMOR: MAYBE THE HEMP MUSEUM WANTS IT. Show folks how kenaf was processed in prehistoric times...
Fancy idea, but not reality.
HEMP could be in hemp museums as historical pioneer at some point, sure. Maybe after decades of use, and it needs to be decommissioned, in preparation of the next, EVEN BIGGER, decorticator.
Way more likely than dinosaurs.
Yes, the "Bruce Perlowin Museum of Historical American Hemp" in Raleigh, North Carolina, just could be.
And HEMP isn't using the decorticator for Kenaf - never has, never will - but will be churning MILLIONS of pounds when the bulk production is in. Fields from hundreds of miles, state over state, will be looking to hemp for processing services. No one will offer cheaper run-rates, and turn around processing any faster than HEMP... no other machine like it in the entire country.
Not Canada...
Not Mexico...
Not South America...
But right here in the good ole USofA, and it's in HEMP INC's hands.
COMPETITION LOST OUT. Sad. Mad. Years behind.
HEMP INC WINNING COAST TO COAST.
One potential strategy to regulate CBD may be to set a threshold. High-dose products could be restricted and require a prescription, while low-dose products similar to many of the CBD oils currently on the market would be widely available.
The hemp industry has signaled its support for this approach. The lower dose products could be sold "over-the-counter in natural food stores, drug stores and grocery stores," says Miller of the U.S. Hemp Roundtable.
As CBD Oils Become More Popular, The FDA Still Has Safety Considerations
Allison Aubrey, NPR
Jun 2
The Food and Drug Administration held its first public hearing on CBD last Friday. The cannabis extract that has quickly grown into a billion-dollar industry, and the FDA expects the results will help officials determine how to regulate CBD products.
The compound can be extracted from marijuana or from hemp. It's promoted as a way to ease anxiety and inflammation – and it doesn't get people high because it doesn't contain THC, the psychoactive component of the cannabis plant.
People are using oils with cannabidiol, or CBD, to help with everything from menstrual cramps to insomnia. While the hype around CBD has gotten ahead of the science, there are a growing number of small studies that do point to some health benefits. But the FDA has concerns over how these products are marketed, and is seeking more data about their safety.
"Questions remain regarding the safety considerations raised by the widespread use of these products," FDA officials wrote in a Federal Register notice about the hearing. "These questions could impact the approaches we consider taking in regulating the development and marketing of products."
Regulators are expected to hear from many players in the CBD industry eager for the agency to step in and set some clear rules, because there's been a cloud of uncertainty over the legality of marketing and selling CBD products.
The 2018 farm bill lifted longtime restrictions on hemp, meaning that hemp would no longer be regulated as a controlled substance. The hemp industry saw this as a green-light to move ahead in promoting CBD products.
"When the farm bill passed last year, we were beyond thrilled. This ended a multi-decade prohibition on hemp," says Jonathan Miller who serves as general counsel to the U.S. Hemp Roundtable, a coalition of dozens of hemp companies. "It was a historic moment."
But the FDA quickly stepped in to make it clear that it has regulatory authority over CBD. The agency has said, for example, that cannabidiol products cannot be sold as dietary supplements.
So the industry is asking for a more definitive set of rules, and the FDA hearing is a first step.
"We really need the FDA to join in and help us lay a path toward a regulated legal product," Miller says. This is the main message he says he'll deliver during today's hearing.
But the FDA has a lot of questions for his industry, and researchers who study cannabis say there's still a lot to learn about cannabidiol.
"We're really in the infancy of understanding the physiological effects of cannabadiol right now," says Ziva Cooper, research director for the UCLA Cannabis Research Initiative.
Cooper says there are important questions to answer, such as: What doses are safe? And what happens when people use it for long periods of time?
The FDA has already approved one drug made of purified CBD, called Epidiolex, which is used to treat two rare and serious forms of epilepsy.
You need a doctor's prescription to get this medication, and it contains a much higher dose of CBD than what people typically get from the oils sold online or in dispensaries or markets.
Clinical trials of Epidiolex found that the high dose of CBD was generally safe but that it did cause side effects in some people, including lethargy and gastrointestinal distress. The FDA also pointed to concerns about possible liver injury.
"This is a potentially serious risk that can be managed when the product is taken under medical supervision in accordance with the FDA approved labeling for the product," agency regulators wrote in the Federal Register notice. "But it is less clear how this risk might be managed if this substance is used far more widely, without medical supervision."
One potential strategy to regulate CBD may be to set a threshold. High-dose products could be restricted and require a prescription, while low-dose products similar to many of the CBD oils currently on the market would be widely available.
The hemp industry has signaled its support for this approach. The lower dose products could be sold "over-the-counter in natural food stores, drug stores and grocery stores," says Miller of the U.S. Hemp Roundtable.
The FDA has set no timeline to regulate CBD products, and its evaluation is likely to continue over the coming months.
Source: https://www.kqed.org/news/11751968/as-cbd-oils-become-more-popular-the-fda-considers-whether-to-set-new-rules
Hemp industry thriving. All the MORE TRUE To date, there are only five decorticators of this magnitude in the world. Hemp, Inc. owns the only one, of this scale, in the United States.
at HEMP INC.
Who is in possession of the LARGEST DECORTICATOR IN THE WESTERN HEMISPHERE? hmmm....
Anyone?
Where would one point?
Not Bluebird...
Not CV Sciences...
Not Cronos...
Not Aurora...
Not little dinky Wyndrige Farm...
Nowhere in Canada...
No, the only one that was able to get there hands on the LARGEST HEMP PROCESSING MACHINE - ONLY FIVE OTHERS LIKE IT IN THE WORLD CURRENTLY IN USE - is none other than HEMP INC.
This is the real deal. Little tinker-toy "hemp trains" not going to be able to keep up with MASSIVE, MONSTER HEMP INC SIZED DECORTICATION OUTPUT.
ECONOMIES OF SCALE ALWAYS PREVAILS.
Bruce and his team saw this coming years ahead of the pack. The competition lost out... missed their opportunity.
TRUER WORDS NEVER BEEN SPOKEN.
And nothing MORE TRUE than HEMP INC DOMINATION.
https://www.quora.com/Which-is-more-grammatically-correct-truer-or-more-truenorth
Oh Grammarnazis and friends...
Time to get on the REAL HEMP TRAIN.
CHOO CHOO!
No one pay any attention to Bruce Perlowins Facebook page. It’s all rumors.
I would say the same is more true for other online forums.
Case is on its second judge? Oh, wow.
(disclaimer: of course I knew the case was reassigned to another judge)
Case reassigned only yet another sign of HOW MUCH TIME has gone by since SEC filed their original CIVIL COMPLAINT.
Sanctions, wanktions. Whatever. Sanctions have been OBJECTED and APPEALED.
And we know the court's stance on the sanctions:
However, because the defendants’ discovery violations do not threaten the rightful decision of the case on the merits, the court will not recommend terminating sanctions.
RUMORS ON FACEBOOK??? BWAAHAHAHAHA!
Who wants to make investment decisions on rumors? Not smart investors. iHub deserves better. Not very honorable or respectable to lend investment advice on RUMORS, imo.
"Hey, guys, hear about the rumor thing on facebook? Looks like HEMP is cooked. Death spiral. Better liquidate all investments. Sell. Sell. Sell."...
What kind of lower than trash garbage is that?
Bruce took this company from a small, fledgling prototype, to now a multi million dollar, coast to coast, BRAND NAME hemp producer, distributor, processor, and educator. Those are ACTUAL facts. Not a rumor. They were saying it would never happen, BUT IS IN FACT HAPPENING.
HEMP is doing it. The news writes about it. The people confirm it. And the SALES show it.
I will stick to facts, please. Rumors can stay on facebook.
Trial date.... yeah... THAT was a lie. Confirmed. Illusions... Sad.
HEMP INC succeeding, and the COMPETITION CRYING. MAYBE DELUSIONAL?
Ay, Bruce, how about we drop another half milly or so on the books. The competition seems to find that appealing. Can't take their eyes away.
HEMP INC, laying the roads and writing the map.
FLOODGATES
NDA BREACHED! SAD!
If disclosing the trail date was under non disclosure, someone better sell the camper and hit the wagon to the Kremlin.
It's clear. It was BAD INFORMATION. Deliberate? Hmmm....
Again, I monitor PACER like a princess monitors pimples.
There was no trial scheduled for May, ever. End of story.
Spin spin spin. Twist twist twist.
The ongoing fickle stock fraud case is just that - fickle, WITHOUT ENOUGH EVIDENCE TO CLOSE THE CASE MONTHS AGO, OR A SIMPLE SETTLEMENT FROM DAY-1.
If there was evidence, it's OPEN AND SHUT. Now we head into the cases long-winded THIRD year, and not much more than a "sanction" for one defendants inability to file tax returns; returns that weren't made from BEFORE the case opened... two mutually exclusive events, hard to claim foul.
OH HEMPBLOWERS, sad ex-associates, grinding axes loud and proud. SEC probably should have looked into who was supplying the tip...
Now it's just a wild goose chase, and still no evidence. Jury just gonna walk out with their hands up, in shrugs, I guess... what a waste of resources and everyone's time.
HEMP INC still making MILLIONS. Industry keeps getting bigger and bigger.
COMPETITION HATES HEMP INC'S SUCCESS. They are in tears, crying out loud.
I asked for a docket number...
I still do not see a docket number showing the originally "scheduled" date as mentioned by others in the past. And, yes, I have access to PACER, know how to pull up dockets... all I need is the docket number and I'll be satisfied. Others have said they've seen the court arranged scheduling within the public filings.... so....
Docket number? POST IT IF YOU GOT IT.
I'm sorry, that is not a docket number or court date...
Do you have either?
Farmers can now legally grow hemp in Arizona
Posted: 2:40 PM, Jun 01, 2019 Updated: 12:58 AM, Jun 02, 2019
By: Jamie Warren
Starting Saturday, farmers can legally grow hemp in Arizona.
The Arizona Hemp Industries Association says those wanting to cash-in on the crop are still waiting for their state-issued licenses. But once they receive them, you'll start seeing some changes across the Valley.
"They're going to send us our license in the mail as soon as everything clears. Finger print cards, etc.," George Buckler, one of about 200 people who applied for a license, said.
Buckler and former GOP Chairman Randy Pullen sit on the board for the Arizona Hemp Industries Association.
"It's a gold rush," Pullen said.
Pullen says you can make about $600 per acre growing hemp.
"Versus making anywhere from $0 to $100 an acre to plant other products," he said.
He says new jobs are also expected to open up, as people like Buckler plan to research how the plant grows best.
"The different researchers around in Arizona, the different solar companies, the different lighting companies," Buckler said.
Farmers are expected to start planting the seeds in the next 30 days.
"We're going to see huge successes and we'll see some that don't do well," Pullen said.
Not long after that, they predict you'll start seeing a change at your local drug store.
"You'll be buying CBD lotions and other products there," Pullen said.
"Part of what it means for you too, is you're going to know exactly where it came from," Buckler said.
Source: https://www.abc15.com/news/state/farmers-can-now-legally-grow-hemp-in-arizona
Farmers are now able to legally grow hemp in Arizona
Posted Jun 01 2019 07:11PM MST
Video Posted Jun 01 2019 09:16PM MST
Updated Jun 01 2019 09:16PM MST
PHOENIX (FOX 10) - It is now officially legal for farmers to grow hemp in the state of Arizona.
The Arizona Hemp Program - launching today - falls under the jurisdiction of the stat'es agriculture department. The program allows hemp to be used to manufacture products and allows them to be shipped across state lines.
Farmers will also be eligible to apply for USDA crop insurance.
Source: http://www.fox10phoenix.com/news/arizona-news/farmers-are-now-able-to-legally-grow-hemp-in-arizona
Just need the docket number. No further information needed.
Have the docket number?
NO DOCKET NUMBER? POST #119467 NON-EXISTENT?
SOMEONE ON FACEBOOK THOUGHT THERE WAS A TRIAL IN MAY, BUT IT'S JUNE AND NO TRIAL?
POST #110466 "IT WAS SCHEDULED FOR MAY"...
WHERE, UNDER GOD'S GREAT SUN, WAS THERE EVER A FORMALIZED TRIAL DATE SCHEDULED?
WHICH CASE DOCKET HAS DATE?
I HAVE ACCESS TO PACER (AS DOES EVERYONE), HAVE BEEN USING PACER TO UPDATE THIS BOARD (ANYONE HERE KNOWS THAT I'VE BEEN MOST ACTIVE ON PACER UPDATES), AND I UNDERSTAND HOW TO USE PACER (IMO, DOESN'T REQUIRE A TUTORIAL - ANYONE WITH MIDDLE SCHOOL COMPETENCE COULD EASILY NAVIGATE AND USE THE SITE).
IN FACT, THERE IS A NEW DOCKET UPDATE TO THE CASE; SEC'S SAD RESPONSE TO OBJECTIONS. OF COURSE THEY OBJECT. AN OBJECTION TO AN OBJECTION, SUCH IS THE ONGOING NO FACTUAL MATTER TO SUBSTANTIATE INITIAL CLAIMS PISS-MATCH OF A CASE, ALL INSTIGATED ON A BOGUS SECRET RECORDING PROVIDED BY AN DISGRUNTLED EX-ASSOCIATE WHISTLETICKLER.
AGAIN, WITH ALL THIS INFORMATION EASILY ACCESSIBLE TO THE PUBLIC, WHEN SIMPLY ASKING FOR A DOCKET # - WE ARE NOW UP TO 146 COURT RECORDED DOCKETS - WHY CAN'T ANYONE POINT TO JUST ONE DOCKET WITH ANY MENTION OF ANY SCHEDULED COURT DATE??????
WHY IS THE INFO SO STIRRED AND MURKY?
JUST SEND THE DOCKET NUMBER, AND I WILL PULL UP THE RUMORED "SCHEDULED FOR MAY" FILE.
Just need the docket number. No further information needed.
Have the docket number?
Where on PACER would one be able to find trial date scheduled for May?
Which docket please, and I'll pull it up.
That is, of course, if a trial date was ever scheduled....
Or maybe some illusion?
Some where saying trial in May. Hard to believe they were wrong...
FDA To Hold Public Hearing On CBD In Food, Drink
By Amelia SantanielloMay 30, 2019 at 5:31 pm
MINNEAPOLIS (WCCO) — The Food and Drug Administration will hold its first public hearing on a plan to legalize cannabidiol, also known as CBD, in food and drinks.
CBD comes from the hemp plant, but it only has trace amounts of tetrahydrocannabinol (THC), which causes the euphoria associated with ingesting marijuana.
CBD has been on sale everywhere, with claims to help with an array of ailments from soreness to stress.
Source: https://minnesota.cbslocal.com/2019/05/30/fda-to-announce-if-cbd-gets-legalized/
NCIA urges FDA to pursue ‘interim fix’ on CBD to reassure banks providing merchant services
31-May-2019 By Elaine Watson
“If we do not succeed in working together to reassure the card brands that they can safely support our industry, then we predict a significant decrease in CBD sales within the next few months,” the National Cannabis Industry Association (NCIA) has warned.
Source: HTTPS://WWW.FOODNAVIGATOR-USA.COM/ARTICLE/2019/05/31/NCIA-URGES-FDA-TO-PURSUE-INTERIM-FIX-ON-CBD-TO-REASSURE-BANKS-PROVIDING-MERCHANT-SERVICES
North Carolina Lawmakers Delay Proposed Ban on Smokable Hemp
By Associated Press
PUBLISHED 7:58 PM ET May. 30, 2019
RALEIGH, N.C. -- A proposed ban on smokable hemp has North Carolina farmers worried as the state Senate agriculture committee considers legislation that would expand industrial hemp farming, which was originally established as a pilot program in 2015.
-Farmers say the ban would hurt their business as some are struggling due to hurricanes and tobacco prices.
-State Bureau of Investigation pushed to ban smokable hemp, saying it's difficult for law enforcement to discern smokable hemp from marijuana.
-Lawmakers amended the bill to delay the smokable hemp ban until Dec. 1, 2020.
Farmers argued at a hearing Thursday that banning smokable hemp would hurt the lucrative hemp industry at a time where many farmers in the traditional tobacco-farming state are struggling due to hurricanes and decreased tobacco prices.
But the State Bureau of Investigation pushed to ban smokable hemp, saying it's difficult for law enforcement to discern smokable hemp from marijuana.
Lawmakers amended the bill to delay the smokable hemp ban until Dec. 1, 2020, giving them time to figure out how to regulate the fast-growing industry. The committee plans to vote on the bill next week.
Source: https://spectrumlocalnews.com/nc/charlotte/news/2019/05/30/north-carolina-lawmakers-delay-proposed-ban-on-smokable-hemp
Ben & Jerry's wants to make a CBD ice cream, but there's a problem
Updated: 5:47 PM PDT May 30, 2019
(KCRA) — Ben & Jerry's said Thursday on its website that it wants to make a CBD-infused ice cream.
There's just one problem -- the FDA prohibits adding CBD to food and beverages.
CBD is a non-psychoactive compound found in cannabis and hemp. It does not contain THC.
The FDA will hold its first public hearing Friday on cannabis and cannabis-derived compounds, the most popular of which is CBD, according to NBC News.
The FDA said it will be looking into the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis.
Ben & Jerry's said it's submitted a comment to the FDA in favor of legalization of CBD-infused foods.
"We’re doing this for our fans,” Ben & Jerry’s CEO Matthew McCarthy said. “We’ve listened and brought them everything from Non-Dairy indulgences to on-the-go portions with our Pint Slices. We aspire to love our fans more than they love us and we want to give them what they’re looking for in a fun, Ben & Jerry’s way.”
The FDA has oversight of CBD because it is the active ingredient in an approved prescription drug to treat two rare seizure disorders. The agency says CBD can't be added to food or sold as a dietary supplement because officials haven't determined if it's safe or effective for other conditions.
Source: https://www.kcra.com/article/ben-and-jerrys-cbd/27671780
CBD business taking off beyond expectations
Posted: Thu 10:05 PM, May 30, 2019 | Updated: Thu 11:39 PM, May 30, 2019
From flavored oils to pain creams, a small CBD shop in Topeka has a variety of options.
The store's owner says customers can buy candy bars, coffee or even pet treats, all including CBD, a cannabinoid made from industrial hemp. It's legal under the National Farm Bill and under Kansas law.
Trevor Burdett is the man behind stores like the one in Topeka. He's the founder of Sacred Leaf, which allows individuals to run their own stores under his name.
The CBD stores have taken off in Kansas and elsewhere. Burdett says they've added 25 stores this year alone, bringing the total to 45 confirmed locations.
Burdett says a 500 square-foot warehouse more than tripled in size to 1,800 square feet. Three months later, there was an even bigger jump as a 6,000 square-foot warehouse is now used, solely for CBD products his shops sell.
Business growth like this isn't normal. One of Burdetts stores in Houston opened in February, making more than $120,000 in sales by April. The first store in Houston started out making a little less than $23,000 per month. In less than a year, that number jumped to six figures, he says.
Forbes estimates the CBD industry will surpass $20 billion in just five years. It's something Burdett says he didn't expect, but he's definitely not fighting it.
CBD can be controversial because many equate it to marijuana and THC. Though by Kansas law, CBD shouldn't have any THC, Burdett says they still have roadblocks. He says they can't promote anything on social media because sites like Facebook and Instagram shut them down, thinking they're selling drugs.
Leasing space is also a challenge, as is banking. Burdett says PayPal froze his assets and his current credit card company shut him down and seized $75,000. He says he knows he's legal, but it's a headache to educate those with preconceived notions while trying to run a business.
Source: https://www.kwch.com/content/news/CBD-business-taking-off-beyond-expectations-510647431.html
USDA: States can't ban hemp trucks once fed regs take effect; link to full story
Posted by Betsy May 30, 2019
States won’t be able to ban the transport of hemp through their states once the U.S. Department of Agriculture publishes hemp production regulations later this year, Post Register reporter Nate Brown writes, according to an advisory opinion from a lawyer for the department.
The opinion also said states already can’t ban the transport of hemp that is grown legally under a 2014 law, and it took issue with a recent ruling in a pending case involving 6,700 pounds of hemp seized in Ada County in January.
The cultivation of hemp, a non-psychoactive cousin of marijuana that has industrial uses such as rope and fabric manufacturing, was legalized federally under the Farm Bill that passed in December. While many states are working on plans to regulate hemp cultivation, Idaho remains one of the few where driving a load of it through the state might get you serious prison time.
Three truckers moving hemp through Idaho have been arrested in Ada County over the past year or so. You can read Brown's full report here at postregister.com, or pick up today's Idaho Press; it's on the front page. (The Post Register is our sister paper; both the Idaho Press and the Post Register in Idaho Falls are owned by Adams Publishing, as is the Idaho State Journal in Pocatello and several smaller Idaho papers.)
Source: https://www.mdjonline.com/neighbor_newspapers/extra/news/usda-states-can-t-ban-hemp-trucks-once-fed-regs/article_91f186c8-4fc9-5bef-ac14-5cbf701ef599.html
Nebraska Governor Pete Ricketts signs hemp bill
Some senators were worried it opens to door to marijuana
Updated: 8:44 PM CDT May 30, 2019
Rob McCartney
Anchor/Reporter
Nebraska farmers can now get into the hemp business.
Governor Pete Ricketts, who had been hesitant to back hemp, signed LB657 into law.
Under the “Nebraska Hemp Farming Act” hemp is now seen as a legal crop, even though it had already been legalized by the U.S. Congress through the 2018 Farm Bill.
Some senators argued that hemp comes from cannabis and allowing hemp production could lead to marijuana.
Under this law, the hemp must contain less than 0.3 percent THC, which is the active ingredient in marijuana.
The law also requires anyone who transports hemp must be able to show where it came from and its destination.
Failure to do that would be a misdemeanor.
Source: https://www.ketv.com/article/motorcyclists-give-back-to-veterans-who-sacrificed-so-much-for-country/27654629
USDA: Hemp OK to take through states
Taylor Six
tsix@richmondregister.com
Kentucky Agriculture Commissioner Ryan Quarles issued a statement proceeding a publication of a legal opinion from the United States Department of Agriculture (USDA) on hemp, clarifying that hemp is a legal agricultural crop that can be moved across state lines.
In the statement, Quarles stated this confirmed something that Kentuckians have been saying all along.
"The 2018 Farm Bill made hemp legal nationwide, and it is unlawful for any state agency to interfere in the transportation of lawfully produced hemp," the statement read. "This announcement provides much-needed certainty for the hemp industry in Kentucky and across the nation."
Sean Southard, the director of communications for the Kentucky Department of Agriculture, said that Quarles appreciates the USDA's opinion.
"And (it) just reiterates what they have said, and that is that hemp is a legally recognized crop and could be transported," Southard said.
The opinion contains four basic provisions regarding the crop and those who grow it:
• As of the enactment of the 2018 Farm Bill on Dec. 20, hemp has been removed from schedule I of the Controlled Substances Act and is no longer a controlled substance.
• After USDA publishes regulations implementing the new hemp production provisions of the 2018 Farm Bill, states and Native American tribes may not prohibit the interstate transportation or shipment of hemp lawfully produced under a state or tribal plan or under a license issued under the USDA plan.
• States and Native American tribes also may not prohibit the interstate transportation or shipment of hemp lawfully produced under the 2014 Farm Bill.
• A person with a state or federal felony conviction relating to a controlled substance is subject to a 10-year ineligibility restriction on producing hemp under the Agricultural Marketing Act of 1946. An exception applies to a person who was lawfully growing hemp under the 2014 Farm Bill before Dec. 20, 2018, and whose conviction also occurred before that date.
The opinion notes that while the 2018 Farm Bill gives state the authority to create and enforce laws that regulate hemp production, they cannot block the legal shipment of hemp through that state or territory.
This ruling should solve issues such as one that occurred in January, when an 18,000-pound shipment of hemp valued at $500,000 was seized in Oklahoma, while being trucked from Louisville to Colorado.
Quarles also said in the release, "USDA Under Secretary Greg Ibach in April … and I discussed lingering issues involving the interstate commerce and transportation of hemp -- issues that continue to hinder the industry even though hemp is a legal agricultural commodity. With around 1,000 licensed hemp growers and more than 56,000 acres of hemp production approved this year in Kentucky, it is important for Kentucky's hemp community to have certainty regarding the interstate transportation of their crop."
Kentucky hemp processors reported $57.75 million in gross product sales last year, more than tripling the 2017 total, according to Quarles. Processors spent $23.4 million in capital improvements and employed a total of 459 people in 2018, he reported.
Source: https://www.richmondregister.com/news/usda-hemp-ok-to-take-through-states/article_72ace2cc-985e-5024-bcc2-68e80c6e593d.html
FDA DECISION APPROACHETH.
FLOODGATES
24 MORE GREENHOUSES!!!???
All the assets?
Not sure as to what would be "bought out", yet acknowledging the assets?
hmmm...
And leveraged? Against what? With whom? And why, now, leveraging assets is foreign or even considered detrimental?
The ASSETS are in the MILLIONS, TODAY! TANGIBLE. Real.
If need be, HEMP has to fire-sale everything tomorrow, whole kit and caboodle, still stands to get some REAL money. Sure, dimes, perhaps pennies on the dollar, but REAL, ACTUAL hard cash money.
Look folks, the equipment is there for everyone to see, and at no charge to shareholders. Heck, I get the feeling that even NONSHAREHOLDERS could simply meander on by on horseback, show up at any moments notice and take a gander, even if offering the claim they are thinking about purchasing just ONE share of HEMP.
It's there. MacTavish, Temafa, the secondary mill and grinder line, the storage, the bays, the fields. Coast to coast. It's all there. It would be very hard, if not IMPOSSIBLE for ANYONE to "prop" and "illusion" that amount of EQUIPMENT and LAND out of existence.
Some do try. Some do try.
Those whom stand in front of...
FLOODGATES
Not just the company, but the person running the company.
It's easy DD, with some forecasting NO FELONS in hemp, and we all know how that panned out. Felons are, indeed, allowed. In fact, some of these felons are in high demand, due to their past experience with the product and services in past dealings with some form of cannabis. Now that laws are changing, what was once outlawed is now legal, and those with past convictions as is relates to the outdated prohibition on cannabis are sought after.
Who more than others? Bruce Perlowin, King of Cannabis, once captain of a billion dollar distribution. And he's still at it, now with laws in favor of cannabis.
Some shady accountants and broker dealers might have been given the boot, which is why we see a lot of cry babies wishing doom on hemp. The competition is fierce and everyone wants to be the king, but there is only one true king to the cannabis throne. We all know who the rightful holder of the throne is, the King of Cannabis, Bruce Perlowin.
Competition hates it. Shareholders ignore the sounds of axes grinding...
What's ahead?
FLOODGATES
FRIDAY 5/31
The U.S. Food and Drug Administration will hold a public hearing to explore how it should regulate cannabis and cannabis-derived compounds, including CBD
FDA sets first hearing on CBD in May as the agency looks at legalizing the cannabis compound in food and drinks
PUBLISHED TUE, APR 2 2019 8:53 AM EDTUPDATED TUE, APR 2 2019 6:52 PM EDT
Angelica LaVito
The Food and Drug Administration has set its first public hearing on legalizing CBD in food and drinks, to figure out how to regulate the newly legalized cannabis product. The hearing will take place on May 31.
The agency wants data on CBD’s safety in food products and feedback on how it might regulate manufacturing, marketing and labeling, according to a notice posted Tuesday in the Federal Register.
Outgoing FDA Commissioner Scott Gottlieb named Principal Deputy Commissioner Amy Abernethy and Principal Associate Commissioner for Policy Lowell Schiller to co-chair a high-level working group tasked with evaluating the issue.
“It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” Gottlieb said in a statement Tuesday.
CBD, short for cannabidiol, is a non-psychoactive compound found in the cannabis plant that promises to relax the body without altering the mind like THC. Congress legalized CBD derived from hemp in December.
This was supposed to lead to a surge in consumer products infused with the cannabis compound. However, the FDA’s rules prohibiting the addition of CBD to food and drinks have kept most large companies on the sidelines, though a number of start-ups have jumped in anyway.
Facing calls from Congress, the FDA has privately been searching for a solution. It will now take its efforts public, first with the meeting, which will take place at its headquarters near Washington, D.C. Gottlieb said the working group plans to share its findings as soon as this summer.
“This is a complicated topic and we expect that it could take some time to resolve fully,” he said. “Nevertheless, we’re deeply focused on this issue and committed to continuing to engage relevant stakeholders as we consider potential paths forward.”
The FDA and the Federal Trade Commission on Tuesday issued warning letters to three companies — Advanced Spine and Pain’s Relievus, Nutra Pure and PotNetwork Holdings — for allegedly making unproven claims about their CBD products, such as helping to treat cancer and Alzheimer’s disease.
“The FDA continues to be concerned about the proliferation of egregious medical claims being made about products asserting to contain CBD that haven’t been approved by the FDA, such as the products and companies receiving warning letters today,” Gottlieb said.
Nutra Pure President CJ Montgomery in an email to CNBC said that compared with “many other CBD-related companies making over-the-top health claims,” the language his company used was “quite minor.” He said the company removed the language “out of an abundance of caution” but is “still seeking affirmation from the FDA on the few remaining issues.”
The other two companies did not immediately respond to CNBC’s request for comment.
Source: https://www.cnbc.com/2019/04/02/fda-sets-first-hearing-on-legalizing-cannabis-compound-cbd.html
Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing
MAY 31, 2019
Date:
May 31, 2019
Time:
May 31, 2019
08:00 AM EDT – 06:00 PM EDT
Location:
White Oak Campus: The Great Room
The Great Room
10903 New Hampshire Ave
Bldg 31 Conference Center, The Great Room (Rm 1503)
Silver Spring, MD 20993
United States
Registration:
http://jifsan.umd.edu/events/preview/99External Link Disclaimer
Organized By:
Food and Drug Administration
Registration for in person attendance and/or to make a presentation/provide oral comments is now closed. Due to space limitations, no same day registration is available for this hearing. Registration to view the hearing via webcast is still available.
FDA Campus Information (e.g., local airports, directions, and local hotels)
Registration:
External Link Disclaimer
As stated in the Federal Register notice, the deadline for requests to attend the hearing in person and/or to make a presentation/provide oral comments during the hearing was May 10th. Registration for in person attendance and/or to make a presentation/provide oral comments is now closed. Due to space and time limitations, only registrants will be permitted to attend the hearing in person. Same day registration for in person attendance is not available for this hearing. If you have already registered, your confirmation to attend the hearing in person and/or to make a presentation/provide oral comments will be provided via email by May 21, 2019. Registration for viewing the hearing via webcast is still open and can be accessed through the Register button above. Registrants can view the hearing via webcast. All meeting attendees and other interested parties are encouraged to submit information to the public docket FDA-2019-N-1482 by July 2, 2019.
Background:
The Food and Drug Administration is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. See the Federal Register notice for more information.
Webcast Information:
FDA will webcast this public hearing. Click here to view the hearing via webcast. Barring any technical difficulties, FDA plans to post a link to the recorded webcast after the hearing.
Submitting Comments:
FDA is establishing a docket for public comment on this hearing. The docket number is FDA-2019-N-1482. The docket will close on July 2, 2019. Submit either electronic or written comments on this public hearing by July 2, 2019. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before July 2, 2019. The Regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of July 2, 2019. Comments received by mail/ hand delivery/ courier (for written/ paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Event Materials
Agenda for the FDA Public Hearing The FDA's Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds (127.01 KB)
Source: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds
U.S. Reviews CBD Amid Pressure to Act Quickly
By Kristine Owram
May 27, 2019, 6:00 AM CDT
The U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound can be included in food and drinks.
Cannabidiol, the formal name for CBD, is rapidly becoming a hot wellness trend following the legalization of hemp in the U.S. in December. Mainstream retailers like CVS Health Corp. already sell CBD creams, sprays and lotions but the substance hasn’t yet been approved for use in food and drinks by the FDA. Unlike its cousin THC, CBD doesn’t give users a high. Instead, it’s pitched as a natural way to fight ailments like insomnia, inflammation and anxiety.
That hasn’t stopped restaurants like burger chain Carl’s Jr. from selling CBD-infused food, as there has been little enforcement.
“From the CBD companies’ perspective, if they don’t keep pushing forward they’re going to miss their window of opportunity to gain market control,” said Robert DiPisa, co-chair of the cannabis law group at New Jersey-based firm Cole Schotz. “As an attorney, I try to read everything that the FDA is putting out, I try to gather as much information as possible to guide them in the best direction I can, but the truth of the matter is everyone is running blind right now.”
This is putting pressure on the FDA to act quickly, but the agency has expressed concern that allowing the substance in food, beverages and supplements will lessen the incentive for pharmaceutical companies to conduct clinical research into the health benefits of CBD.
In announcing the May 31 hearings, then-FDA Commissioner Scott Gottlieb said in a statement that there are “open questions about whether some threshold level of CBD could be allowed in foods without undermining the drug approval process or diminishing commercial incentives for further clinical study of the relevant drug substance.”
This indicates that the FDA will set a limit on how many milligrams of CBD can be incorporated into food and drinks, DiPisa said.
Clinical Research
“What they might end up doing is reserve the higher dosages of CBD for pharmaceutical drugs and only permit lower dosages to be incorporated in food and drinks,” he said. “That in itself would hopefully keep an incentive for the pharmaceutical companies to continue to invest in clinical research.”
The market implications are huge: analysts at Piper Jaffray & Co. estimated that the U.S. CBD market could be worth as much as $15 billion in five years. Looser regulations would also give U.S. cannabis companies an advantage over their counterparts in Canada, where CBD products are treated the same way as all cannabis. This means they can only be produced by licensed companies and sold in legal dispensaries. CBD is also restricted to the same product formats as cannabis, meaning only dried flower and oils are currently legal. Those will be joined by edibles, extracts and topicals later this year in Canada.
Regulating CBD is in the best interest of companies and consumers, said Bruce Linton, chief executive officer of Canadian pot company Canopy Growth Corp., which is in the process of building a 308,000 square foot CBD extraction and manufacturing facility in Kirkwood, New York.
“The principal challenge of CBD is there’s not a verified process to create the resulting products so it can’t be consistently defined,” Linton said in an interview. “Our argument is that you need to regulate it so we can actually get it stabilized and then deliver you the data you want.”
It’s critical that the FDA move quickly or ask Congress to draft new laws if it can’t get regulations in place fast enough, said DiPisa. In the meantime, the agency has been forced to crack down on companies making unproven claims about CBD’s effectiveness as a drug. Examples cited by the FDA include claims that CBD can help treat cervical cancer and Alzheimer’s disease.
“We need to get the rules in place sooner rather than later to make sure that the outliers that are doing things they’re not supposed to can fall in line or the FDA can go after them,” DiPisa said.
Upcoming Events This Week
TUESDAY 5/28
Canopy Rivers Inc., the venture capital arm of Canopy Growth Corp., holds an analyst and investor day in Toronto
Acreage Holdings Inc. and Charlotte’s Web Holdings Inc. report earnings post-market
WEDNESDAY 5/29
The Cannabis World Congress and Business Expo runs in New York City through June 1
Trulieve Cannabis Corp., MedMen Enterprises Inc., Green Growth Brands Inc., Origin House and Cresco Labs Inc. report earnings
THURSDAY 5/30
Curaleaf Holdings Inc., Planet 13 Holdings Inc., iAnthus Capital Holdings Inc., Green Thumb Industries Inc., WeedMD Inc. and Emerald Health Therapeutics Inc. report earnings
FRIDAY 5/31
The U.S. Food and Drug Administration will hold a public hearing to explore how it should regulate cannabis and cannabis-derived compounds, including CBD
Source: https://www.bloomberg.com/news/articles/2019-05-27/u-s-reviews-cbd-amid-pressure-to-act-quickly-cannabis-weekly
TSA Updates Marijuana Rules To Allow Hemp-Derived CBD On Flights
Published on May 27, 2019 By Kyle Jaeger
The Transportation Security Administration (TSA) updated its policy on cannabis over the Memorial Day weekend, changing the medical marijuana section of its “What Can I Bring?” webpage from reading “no” to “yes” (with “special instructions”).
Specifically, the agency is clarifying that hemp-derived CBD products may now be carried on planes under certain circumstances.
Previously, TSA made no distinction between marijuana and hemp-derived preparations and warned on its website that cannabis products cannot be taken as carry-on items or in checked bags. But since the 2018 Farm Bill federally legalized hemp and its derivatives, that’s no longer the case.
Now the agency’s webpage specifies that possession of “certain” cannabis products are illegal under federal law, and TSA agents are required to report suspected violations such as possession of “certain” products to law enforcement.
Here’s the new policy as it appears on TSA’s website:
“Products/medications that contain hemp-derived CBD or are approved by the FDA are legal as long as it is produced within the regulations defined by the law under the Agriculture Improvement Act 2018,” a new section states.
Here’s what the TSA policy looked like prior to the update:
It’s not clear how the agency plans to enforce the new policy, unless it intends to train agents to test CBD preparations for the presence of THC and maintain a database of products that are approved by the Food and Drug Administration.
A TSA spokesperson told Marijuana Moment in an email that the policy change was spurred by FDA’s approval of a cannabis-derived anti-seizure medication, Epidiolex.
“TSA was made aware of an FDA-approved drug that contains CBD oil for children who experience seizures from pediatric epilepsy,” the spokesperson wrote. “To avoid confusion as to whether families can travel with this drug, TSA immediately updated TSA.gov once we became aware of the issue.”
But FDA approved the CBD prescription drug nearly a year ago—calling into question the notion that TSA acted “immediately.”
And the representative was not immediately able to comment on part of the TSA website update that now references the broader legalization of hemp-derived CBD under the Farm Bill, which was enacted in December.
The rest of the TSA page on cannabis mostly retains language from the earlier version. The agency’s efforts are “focused on security and are designed to detect potential threats to aviation and passengers,” it says, so it doesn’t use resources to seek out illicit drugs.
However, “if any illegal substance is discovered during security screening, TSA will refer the matter to a law enforcement officer.”
TSA has gone back-and-forth on its marijuana policy as more states opt to legalize the plant for medical or adult use. In April 2017, the agency took advocates by surprise after it updated the medical marijuana section of the “What Can I Bring?” page to include a green “yes,” indicating that medical cannabis was permitted in carry ons or checked bags.
“TSA security officers do not search for marijuana or other drugs,” the page said at the time. “In the event a substance that appears to be marijuana is observed during security screening, TSA will refer the matter to a law enforcement officer.”
But shortly after the page started attracting press attention, TSA temporarily removed the medical cannabis section and tweeted that a “mistake was made in the database.”
The agency later posted an updated version of the page, which specified that marijuana was not in fact allowed on planes.
“Whether or not marijuana is considered legal under local laws is not relevant to TSA screening because TSA is governed by federal law,” TSA wrote. “Federal law provides no basis to treat medical marijuana any differently than non-medical marijuana.”
But with the legalization of industrial hemp and its derivatives, multiple federal agencies are now revisiting their policies to clarify what is and isn’t allowed.
The U.S. Patent and Trademark Office released a memo earlier this month stipulating that certain hemp products may qualify for registered trademarks. The Alcohol and Tobacco Tax and Trade Bureau said in April that CBD cannot currently be added to alcoholic beverages, as the FDA has yet to release updated guidelines on adding hemp-derived products into the food supply.
The U.S. Department of Agriculture (USDA) has told industry stakeholders that they are allowed to import hemp seeds from other countries, and the agency also said it was accepting intellectual property protection applications.
Both the FDA and the USDA are in the process of developing broader regulatory guidelines for hemp and its derivatives, with the FDA set to hold a public hearing on the issue this Friday.
Source: https://www.marijuanamoment.net/tsa-updates-marijuana-rules-to-allow-hemp-derived-cbd-on-flights/
BILLIONS and BILLIONS.
The market continues to exceed growth, and beyond.
Hemp Inc already making MILLIONS per quarter.
Retail EXPANSION.
BIGGER extractor.
24 MORE GREENHOUSES.
MORE HEMP.
MORE JOBS.
MORE STATES.
FLOODGATES
CBD Market Could Reach $20 Billion By 2024, Says New Study
Iris Dorbian
May 20, 2019, 12:49pm
Affecting industries as diverse as cosmetics, food and beverage and pharmaceuticals, the exploding CBD (cannabidiol) market has generated considerable headlines, providing fodder to umpteenth analysis and forecasts. The latest one, by leading cannabis researchers BDS Analytics and Arcview Market Research, projects that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024. Interestingly, this figure is a slight increase from than the recent forecast made by New York-based investment bank Cowen & Co, which estimated that the market could pull in $15 billion by 2025.
The new forecast takes into account products sold through licensed dispensaries, pharmaceuticals and in general market retail, which includes cafes, smoke shops, grocery stores and pharmacies. However, BDS Analytics predicts that the majority of CBD product sales will soon occur in general retail stores instead of cannabis dispensaries. When you consider how cannabis has become increasingly integrated into mainstream society, as represented by the number of states that have legalized recreational or medical markets (33 and D.C for recreational use and 10 states plus D.C. for adult use), the BDS prognostication makes perfect sense.
But sales will continue from other distribution channels. In fact, BDS Analytics is predicting an compound annual growth rate of 49 percent by 2024 across all distribution channels. Also, they expect that the CBD market, combined with THC products, will create a total market of $45 billion for cannabinoids by 2014.
Other findings from the new study include:
-CBD product sales in dispensaries since 2014 have grown at an even faster rate than overall sales in dispensaries;
-66 percent of hemp-derived CBD consumers in the U.S. agree with full federal legalization of cannabis, with 90 percent believing that marijuana has medical benefits; and
-CBD consumers are an average age of 40, have higher education, and are more likely than non-consumers to be employed full time.
Jessica Lukas, vice president of consumer insights at BDS Analytics, explained how the Boulder, Colorado-based firm cast this latest forecast. “We had to look at the landscape today, and then assess and predict where the market will go,” she said. “THC and CBD are very different with different functionality. Product forms that make sense and are very successful for THC do not necessarily transfer to CBD. Additionally, we had to strongly consider the interaction between the general market channels and the dispensary channel in assessing whether or not the availability of CBD products in the general market is incremental to purchases in dispensaries, will replace dispensary purchases, and/or will drive greater penetration and acceptance of legal cannabis.”
Estimating the size of the market by channel and category was a challenge in the data-gathering process. “Most products being sold in the general market today are in untracked channels of distribution,” said Lukas. Yet even with this problem, she is expecting many categories (food, candy, beverages, beauty, skin, etc.) will generate substantial volume across many channels of distribution. “While dispensaries and ecommerce drive the majority of cannabinoid sales today in the U.S, this shifts versus the next five years,” she added.
Source: https://www.forbes.com/sites/irisdorbian/2019/05/20/cbd-market-could-reach-20-billion-by-2024-says-new-study/#32f3eb8049d0
Hemp, Inc. also announced, recently, that it is encouraging large-scale companies to secure their hemp biomass now. There is an increasing demand to use high CBD hemp biomass for the production of CBD distillate and CBD isolate. CBD hemp is a very attractive source of Biomass, especially when good yields can be produced in very large commercial quantities. Hemp, Inc. will be growing up to 25,600 acres of industrial hemp, (40 square miles) to be sold as hemp biomass. According to Perlowin, that amount won’t come close to fulfilling the market demand based on what Hemp, Inc. has already received so far in requests for biomass. (Be sure to get your hemp biomass now before Hemp, Inc.’s supply runs out.)
Lol, the appropriate time.
When is that?
1YR-2YR-3YR-FOUR!
Everyday, the sales are going up!
https://i.gifer.com/liI.gif